Lipocine (LPCN) Metrics: History & Chart

Lipocine Inc.(LPCN)

Biotechnology · Salt Lake City, UT

$2.08+0.01 (+0.48%)

Delayed quote: Oct 6, 2026, 11:55 AM EDT

About Lipocine Inc.

Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost investigational therapy is TLANDO, an oral solution for testosterone replacement. The company's development pipeline also encompasses several other promising candidates: LPCN 1144: An orally administered prodrug derived from bioidentical testosterone, which has successfully completed Phase II clinical trials for the treatment of non-cirrhotic non-alcoholic steatohepatitis. LPCN 1111: An oral prodrug of testosterone tridecanoate, engineered for once-daily administration, and having also concluded Phase II clinical studies in men experiencing hypogonadism. LPCN 1148: A novel prodrug combining testosterone and testosterone laurate, designed for the management of decompensated cirrhosis. LPCN 1154: An investigational new drug application has been submitted to initiate a Phase 2 study targeting Postpartum Depression. LPCN 2101: A compound intended for women with epilepsy, which has progressed beyond its pre-clinical study phase. LPCN 1107: An oral hydroxyprogesterone caproate product, which has completed its dose-finding Phase II clinical trial aimed at preventing recurrent preterm birth. The corporate headquarters for Lipocine Inc. are located in Salt Lake City, Utah.

Salt Lake City, UT

14 employees

www.lipocine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mahesh V. Patel

View full financials

Third-Party DCF Estimate (FMP)	$0.67
Price Gap vs Third-Party Estimate	-67.52%

7D Total Return	-0.96%
30D Total Return	-15.51%
YTD Total Return	-74.22%
1Y Total Return	-38.21%
3Y Total Return	-25.54%
5Y Total Return	-88.18%
10Y Total Return	-97.17%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-74.22%
2025	+64.55%
2024	+74.91%
2023	-58.79%
2022	-59.82%
2021	-27.12%
2020

CAGR TTM	-38.07%
CAGR 3Y	-9.36%
CAGR 5Y	-34.76%
CAGR 10Y	-29.99%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	29093253592813404.00
PE Ratio Avg TTM	29275707116178672.00
PE Ratio Avg 3Y	14.59
Current VS TTM Avg	-0.62%
Current VS 3Y Avg	+199419292215822784.00%
Current VS 5Y Avg	+199419292215822784.00%

All Metrics

LPCN Valuation Metrics

LPCN Stock Price Metrics

LPCN Dividend Metrics

LPCN Growth Rate Metrics

LPCN Discounted Cash Flow Metrics

LPCN Returns By Period

LPCN Yearly Returns

LPCN Average Annual Returns By Period (CAGR)

LPCN Revenue Metrics

LPCN PE Ratio Metrics

LPCN PS Ratio Metrics

LPCN PB Ratio Metrics

LPCN Price to Free Cash Flow Ratio Metrics

LPCN Debt to Equity Ratio Metrics

LPCN PEG Ratio Metrics

LPCN FCF Yield

LPCN Earnings Yield

LPCN EBITDA Yield

LPCN OCF Yield

LPCN EV/EBIT Ratio Metrics

LPCN EV/EBITDA Ratio Metrics

LPCN EV/Assets Ratio Metrics

LPCN EV/Sales Ratio Metrics

LPCN Current Ratio Metrics

LPCN Quick Ratio Metrics

LPCN ROIC Metrics

LPCN Return on Assets Metrics

LPCN Return on Equity Metrics

LPCN Net Profit Margin Metrics

LPCN Gross Profit Margin Metrics

LPCN Tax Rate Metrics

PS Ratio	10.84
PS Ratio Avg TTM	8.08
PS Ratio Avg 3Y	5.90
Current VS TTM Avg	+34.20%
Current VS 3Y Avg	+83.83%
Current VS 5Y Avg	+94.63%

PB Ratio	0.78
PB Ratio Avg TTM	1.52
PB Ratio Avg 3Y	1.00
Current VS TTM Avg	-48.60%
Current VS 3Y Avg	-22.11%
Current VS 5Y Avg	-28.14%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.00%
Earnings Yield Avg TTM	0.00%
Earnings Yield Avg 3Y	5.85%
Current VS TTM Avg	N/A
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	7.79
Ev/Ebit Ratio Avg TTM	17.39
Ev/Ebit Ratio Avg 3Y	17.39
Current VS TTM Avg	-55.21%
Current VS 3Y Avg	-55.21%
Current VS 5Y Avg	-55.21%

Ev/Ebitda Ratio	7.77
Ev/Ebitda Ratio Avg TTM	17.37
Ev/Ebitda Ratio Avg 3Y	17.37
Current VS TTM Avg	-55.27%
Current VS 3Y Avg	-55.27%
Current VS 5Y Avg	-55.27%

Ev/Assets Ratio	0.50
Ev/Assets Ratio Avg TTM	1.10
Ev/Assets Ratio Avg 3Y	0.71
Current VS TTM Avg	-54.60%
Current VS 3Y Avg	-29.42%
Current VS 5Y Avg	-46.37%

Ev/Sales Ratio	7.66
Ev/Sales Ratio Avg TTM	6.14
Ev/Sales Ratio Avg 3Y	4.63
Current VS TTM Avg	+24.67%
Current VS 3Y Avg	+65.58%
Current VS 5Y Avg	+65.04%

Current Ratio	11.48
Current Ratio Avg TTM	9.82
Current Ratio Avg 3Y	12.04
Current VS TTM Avg	+16.88%
Current VS 3Y Avg	-4.66%
Current VS 5Y Avg	-11.08%

Quick Ratio	11.48
Quick Ratio Avg TTM	9.82
Quick Ratio Avg 3Y	12.04
Current VS TTM Avg	+16.88%
Current VS 3Y Avg	-4.66%
Current VS 5Y Avg	-11.08%

ROIC	(57.74%)
ROIC Avg 3Y	(48.52%)
ROIC Avg 5Y	(40.90%)
Current VS 3Y Avg	-19.00%
Current VS 5Y Avg	-41.16%
Current VS 10Y Avg	-10.25%

ROA	(49.72%)
ROA Avg TTM	(14.22%)
ROA Avg 3Y	(12.58%)
Current VS TTM Avg	-249.55%
Current VS 3Y Avg	-295.16%
Current VS 5Y Avg	-357.19%

ROE	(54.45%)
ROE Avg TTM	(47.21%)
ROE Avg 3Y	(42.90%)
Current VS TTM Avg	-15.33%
Current VS 3Y Avg	-26.93%
Current VS 5Y Avg	-60.20%

Net Profit Margin	(755.13%)
Net Profit Margin Avg TTM	(1559.50%)
Net Profit Margin Avg 3Y	(1073.53%)
Current VS TTM Avg	+51.58%
Current VS 3Y Avg	+29.66%
Current VS 5Y Avg	+0.39%

Gross Profit Margin	(334.26%)
Gross Pft Margin Avg TTM	28.64%
Gross Pft Margin Avg 3Y	80.57%
Current VS TTM Avg	-1266.94%
Current VS 3Y Avg	-514.86%
Current VS 5Y Avg	-629.94%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%